BDBM350652 US10208071, Compound 114::US10434112, Compound 114::diethyl ({[(2S,3S)-2-{[(4- bromophenyl)carbamoyl]amino}- 3-methylpentanoyl]amino} methyl)phosphonate

SMILES CCOP(=O)(CNC(=O)[C@@H](NC(=O)Nc1ccc(Br)cc1)[C@@H](C)CC)OCC

InChI Key InChIKey=GYEVVHHFAVPXOX-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 350652   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350652(diethyl ({[(2S,3S)-2-{[(4- bromophenyl)carbamoyl]a...)
Affinity DataEC50:  2.90nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350652(diethyl ({[(2S,3S)-2-{[(4- bromophenyl)carbamoyl]a...)
Affinity DataEC50:  2.90E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent